Search

for
Search:

Research

5 / 1000+ results

research Management of Serious Adverse Events Following Deoxycholic Acid Injection for Submental and Jowl Fat Reduction: A Systematic Review and Management Recommendations

5 citations , January 2024 in “Aesthetic Surgery Journal Open Forum”

This review notes that while ATX-101 showed a favorable safety profile for reducing submental fat in clinical trials, serious adverse events related to procedures have been reported in real-world use, prompting recommendations for improved management and prevention strategies.

Association of Frailty Index with Clinical Benign Prostatic Hyperplasia Progression and Serious Adverse Events: The MTOPS Trial

research Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial

December 2021 in “Innovation in aging”

This study found that frailty independently raises the risk of clinical BPH progression and serious adverse events in older men, suggesting that shared decision-making is essential when considering medical therapy for frail patients.

research Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial

December 2021 in “Innovation in Aging”

This study found that family caregivers reported significantly longer sleep onset latency compared to carefully matched non-caregiving controls, with depressive symptoms predicting poorer sleep quality among caregivers.

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

research Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

6 citations , February 2023 in “Advances in Therapy”

This study found that patients with rheumatoid arthritis, atopic dermatitis, and alopecia areata receiving baricitinib had low incidence rates of adverse events, especially among low-risk individuals, with varying rates among those at higher risk.

research Reporting on Adverse Clinical Events

July 2017 in “Clin-Alert”

Different medications can cause serious side effects in some people.

View more "serious adverse events" in research →

Community Join

5 / 1000+ results

community Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study

93 upvotes 1 month ago

Oral dutasteride 0.5 mg combined with oral minoxidil 2.5 mg is highly effective for male androgenetic alopecia, showing over 60% improvement and 98% stabilization at 6 months, with low adverse event rates. Patients with severe baseline conditions respond better and faster to this treatment.

community What has the evidence been on side effects with CB?

4 upvotes 6 years ago

Clascoterone (CB) shows an excellent safety profile with no serious side effects, but its effectiveness may decline after six months, making it more suitable as an adjunct treatment with finasteride and minoxidil rather than a standalone solution. Some argue it could be better than finasteride due to its protection against testosterone, but its long-term efficacy remains debated.

community New warning by FDA on topical finasteride

in Research/Science 194 upvotes 1 year ago

The FDA warned that topical finasteride can cause serious side effects like sexual dysfunction and brain fog, similar to oral finasteride. Compounded topical formulations pose additional risks due to lack of regulation.

community Drug restored full hair in 23% and over 80% of hair in 55% in 6 months

240 upvotes 2 weeks ago

An arthritis drug restored significant hair in people with alopecia areata, but it is not effective for male pattern baldness. The drug, Upadacitinib, has serious side effects and is expensive.

community KX-826 Phase 3 Results Are Out

121 upvotes 6 months ago

KX-826 shows promising results for hair growth with fewer side effects, offering an alternative to finasteride and minoxidil. Users discuss combining it with minoxidil, dermarolling, and Nizoral for improved results.

View more "serious adverse events" in community →

Learn

3 / 801 results

learn HMI-115

Is HMI-115 considered a safe option, or does it have strong side effects? HMI-115 is an experimental injected antibody, not a hormone blocker: the one published trial (in endometriosis) reported an acceptable 12-week tolerability profile with no treatment-related serious adverse events, and no peer-reviewed safety data exists for its use in hair loss.

learn Overview

learn Hair Transplant

What are the risks and side effects of a hair transplant? Common risks include swelling, redness, infection, scarring, and temporary hair loss.

View more "serious adverse events" in learn →

Clinics

1 / 7 results

59
TrichologyHair Loss Treatments
Glam 4 EventsRoseville, CA · US

Experts

— no results

Try a deeper search in experts →